SEC filing · 8-K

Neurocrine Biosciences Inc: Executive or director change

Neurocrine Biosciences appointed Eiry W. Roberts, M.D., as Chief Medical Officer to succeed Sanjay Keswani, M.D.

Filed September 28, 2026

Neutral news

What happened

On September 25, 2026, Dr. Keswani and the Board mutually agreed that his service as Chief Medical Officer would terminate as of that date.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Neurocrine Biosciences Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.